Assessment of insulin resistance by a 13C glucose breath test: a new tool for early diagnosis and follow-up of high-risk patients
Open Access
- 27 May 2010
- journal article
- research article
- Published by Springer Science and Business Media LLC in Nutrition Journal
- Vol. 9 (1), 25
- https://doi.org/10.1186/1475-2891-9-25
Abstract
Insulin resistance (IR) plays an important role in the pathogenesis of diabetes and non-alcoholic fatty liver disease (NAFLD). Current methods for insulin resistance detection are cumbersome, or not sensitive enough for early detection and follow-up. The BreathID® system can continuously analyse breath samples in real-time at the point-of-care. Here we determined the efficacy of the BreathID® using the 13C-Glucose breath test (GBT) for evaluation of insulin resistance. Twenty healthy volunteers were orally administered 75 mg of 13C-glucose 1-13C. An oral glucose tolerance test (OGTT) was performed immediately; followed by serum glucose and insulin level determinations using GBT. GBT and OGTT were repeated following exercise, which alters insulin resistance levels. Within-subject correlations of GBT parameters with serum glucose and serum insulin levels were high. Before and after exercise, between-subjects correlations were high between the relative insulin levels and the % dose recoveries at 90 min (PDR 90), and the cumulative PDRs at 60 min (CPDR 60). Pairwise correlations were identified between pre-exercise Homeostasis Model Assessment (HOMA) IR at 90 min and PDR 90; HOMA B (for beta cell function) 120 and CPDR 30; HOMA IR 60 and peak time post-exercise; and HOMA B 150 with PDR 150. The non-invasive real-time BreathID® GBT reliably assesses changes in liver glucose metabolism, and the degree of insulin resistance. It may serve as a non-invasive tool for early diagnosis and follow up of patients in high-risk groups.Keywords
This publication has 35 references indexed in Scilit:
- Review article: current management of non‐alcoholic fatty liver disease and non‐alcoholic steatohepatitisAlimentary Pharmacology & Therapeutics, 2008
- Innate immunity, insulin resistance and type 2 diabetesTrends in Endocrinology & Metabolism, 2008
- Nonalcoholic Fatty Liver Disease: Pathogenesis and Potential for Nuclear Receptors as Therapeutic TargetsMolecular Pharmaceutics, 2007
- Exercise-Induced Alterations in Muscle Lipid Metabolism Improve Insulin SensitivityExercise and Sport Sciences Reviews, 2007
- Review article: the assessment of liver function using breath testsAlimentary Pharmacology & Therapeutics, 2007
- Insulin resistance and the metabolic syndrome—or the pitfalls of epidemiologyDiabetologia, 2007
- Insulin Resistance ConceptsDiabetes Care, 2007
- The insulin resistance syndrome: physiological considerationsDiabetes and Vascular Disease Research, 2007
- Strategies in ongoing clinical trials to reduce cardiovascular disease in patients with diabetes mellitus and insulin resistanceThe American Journal of Cardiology, 2004
- Methods for clinical assessment of insulin sensitivity and β-cell functionBest Practice & Research Clinical Endocrinology & Metabolism, 2003